Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 18Rhabdomyosarcoma 9Dendritic Cell Sarcoma, Interdigitating 9Osteosarcoma 8Neuroblastoma 8Sarcoma, Ewing 7Burkitt Lymphoma 7Wilms Tumor 6Retinoblastoma 6Medulloblastoma 6Lymphoma 6Leukemia, Myeloid, Acute 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Myelodysplastic Syndromes 5Lymphoma, Non-Hodgkin 5Astrocytoma 5Rhabdoid Tumor 4Recurrence 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Juvenile 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 4Hepatoblastoma 4Central Nervous System Neoplasms 4Carcinoma, Renal Cell 4Brain Neoplasms 4Testicular Neoplasms 3Optic Nerve Glioma 3

Interventions

Doxorubicin 18Ifosfamide 13Radiotherapy 8Paclitaxel 7pazopanib 6pembrolizumab 4Gemcitabine 4Filgrastim 4Chemotherapy, Adjuvant 4Bevacizumab 4spartalizumab 3durvalumab 3Sorafenib 3Propranolol 3Nivolumab 3Ipilimumab 3Imatinib Mesylate 3Etoposide 3Epirubicin 3Docetaxel 3Carboplatin 3trebananib 2regorafenib 2cixutumumab 2cemiplimab 2carotuximab 2brostallicin 2belinostat 2balstilimab 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangiosarcoma × Granulocyte Colony-Stimulating Factor × Sarcoma × Clear all
NCT05799612 2026-02-13

Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous Angiosarcoma

M.D. Anderson Cancer Center

Phase 1 Withdrawn
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡